148 related articles for article (PubMed ID: 22126547)
1. Multivariate analysis of prognostic factors in gastric cancer patients using additive hazards regression models.
Maroufizadeh S; Hajizadeh E; Baghestani AR; Fatemi SR
Asian Pac J Cancer Prev; 2011; 12(7):1697-702. PubMed ID: 22126547
[TBL] [Abstract][Full Text] [Related]
2. Multivariate analysis of prognostic factors in gastric cancer patients using additive hazards regression models.
Maroufizadeh S; Hajizadeh E; Baghestani AR; Fatemi SR
Asian Pac J Cancer Prev; 2011; 12(4):901-7. PubMed ID: 21790223
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in gastric cancer using log-normal censored regression model.
Pourhoseingholi MA; Moghimi-Dehkordi B; Safaee A; Hajizadeh E; Solhpour A; Zali MR
Indian J Med Res; 2009 Mar; 129(3):262-7. PubMed ID: 19491418
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Aalen's additive and Cox proportional hazards models for breast cancer survival: analysis of population- based data from British Columbia, Canada.
Abadi A; Saadat S; Yavari P; Bajdik C; Jalili P
Asian Pac J Cancer Prev; 2011; 12(11):3113-6. PubMed ID: 22393999
[TBL] [Abstract][Full Text] [Related]
5. Postoperative life expectancy in gastric cancer patients and its associated factors.
Zeraati H; Mahmoudi M; Kazemnejad A; Mohammed K
Saudi Med J; 2005 Aug; 26(8):1203-7. PubMed ID: 16127513
[TBL] [Abstract][Full Text] [Related]
6. Survival in gastric cancer patients: univariate and multivariate analysis.
Moghimi-Dehkordi B; Safaee A; Ghiasi S; Zali MR
East Afr J Public Health; 2009 Apr; 6 Suppl(1):41-4. PubMed ID: 20084985
[TBL] [Abstract][Full Text] [Related]
7. Effect of demographic and clinicopathologic factors on prognosis of early gastric cancer in Iran.
Moghimi-Dehkordi B; Safaee A; Pourhoseingholi MA; Zali MR
Asian Pac J Cancer Prev; 2008; 9(4):585-8. PubMed ID: 19256743
[TBL] [Abstract][Full Text] [Related]
8. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
9. Estimating postoperative survival of gastric cancer patients and factors affecting it in Iran: Based on a TNM-7 Staging System.
Zeraati H; Amiri Z
Acta Med Iran; 2016 Feb; 54(2):114-8. PubMed ID: 26997598
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic prognostic factors in patients with Borrmann type 4 gastric cancer: univariate and multivariate analyses.
Yokota T; Kunii Y; Saito T; Teshima S; Narushima Y; Yamada Y; Iwamoto K; Kagami M; Takahashi M; Kikuchi S; Yamauchi H
Ups J Med Sci; 2000; 105(3):227-34. PubMed ID: 11261608
[TBL] [Abstract][Full Text] [Related]
11. Significant prognostic factors in patients with early gastric cancer.
Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of lymphatic vessel invasion in early gastric cancer: a retrospective study of 188 cases.
Liu C; Zhang R; Lu Y; Li H; Lu P; Yao F; Jin F; Xu H; Wang S; Chen J
Surg Oncol; 2010 Mar; 19(1):4-10. PubMed ID: 19042124
[TBL] [Abstract][Full Text] [Related]
13. Metastatic lymph node ratio and prognosis of gastric cancer at different pT stages.
Li X; Liu Y; Cao B; Liu B; Bai T; Li X; Mei L; Che X
Hepatogastroenterology; 2015; 62(138):507-11. PubMed ID: 25916091
[TBL] [Abstract][Full Text] [Related]
14. Bayesian analysis for survival of patients with gastric cancer in Iran.
Baghestani AR; Hajizadeh E; Fatemi SR
Asian Pac J Cancer Prev; 2009; 10(5):823-6. PubMed ID: 20104972
[TBL] [Abstract][Full Text] [Related]
15. Early gastric cancer: univariate and multivariate analysis for survival.
Tuech JJ; Cervi C; Pessaux P; Villapadierna F; Bergamaschi R; Ronceray J; Arnaud JP
Hepatogastroenterology; 1999; 46(30):3276-80. PubMed ID: 10626201
[TBL] [Abstract][Full Text] [Related]
16. Multivariate prognostic study on large gastric cancer.
Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
[TBL] [Abstract][Full Text] [Related]
17. Can superextended lymph node dissection be justified for gastric cancer with pathologically positive para-aortic lymph nodes?
Tokunaga M; Ohyama S; Hiki N; Fukunaga T; Aikou S; Yamaguchi T
Ann Surg Oncol; 2010 Aug; 17(8):2031-6. PubMed ID: 20182811
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer.
Qu JL; Qu XJ; Li Z; Zhang JD; Liu J; Teng YE; Jin B; Zhao MF; Yu P; Shi J; Fu LY; Wang ZN; Liu YP
PLoS One; 2015; 10(6):e0128540. PubMed ID: 26075713
[TBL] [Abstract][Full Text] [Related]
19. A comparison between Cox proportional hazard models and logistic regression on prognostic factors in gastric cancer.
Moghimi-Dehkordi B; Safaee A; Tabei SZ
East Afr J Public Health; 2009 Apr; 6 Suppl(1):20-2. PubMed ID: 20084981
[TBL] [Abstract][Full Text] [Related]
20. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
